Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial

Autor: Maghbooli, Zhila, Sahraian, Mohammad Ali, Jamalimoghadamsiahkali, Saeidreza, Asadi, Asma, Zarei, Azadeh, Zendehdel, Abolfazl, Varzandi, Tarlan, Mohammadnabi, Sara, Alijani, Neda, Karimi, Mehrdad, Shirvani, Arash, Holick, Michael F.
Zdroj: In Endocrine Practice December 2021 27(12):1242-1251
Databáze: ScienceDirect